ArticlePloS one2021

The combination of the NS5A and cyclophilin inhibitors results in an additive anti-HCV inhibition in humanized mice without development of resistance.

Michael Bobardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.